Korean Market
OTHR
KMPHARMACEUTICAL
★

KMPHARMACEUTICAL Proposes Charter and Compensation Rule Changes; Related Party Loan Risks Under Spotlight

 
OWNR
KMPHARMACEUTICAL
★

Executive Director Im Yeong-ae's Shareholding Reduced to 787 from 3,935 Due to Reverse Stock Split, Ownership Ratio Unchanged at 0.01%

 
OWNR
KMPHARMACEUTICAL
★

Major Shareholder Kang Il-mo's Shares Reduced to 2,098,052 via 5:1 Stock Consolidation; Ownership Unchanged at 37.62%

 
PERI
KMPHARMACEUTICAL
★

KM Pharmaceutical Corrects Clerical Errors in Q1 Report and Approves Stock Split... Persistent Losses and Financial Risks Remain

 
EXCH
KMPHARMACEUTICAL
★

Trading Suspension Lifted Due to Reverse Stock Split and Change of Listing (2026.05.19)

 
PERI
KMPHARMACEUTICAL
★★

KM Pharmaceutical: Q1 Sales 4.47B Won, Operating Loss 0.66B Won, Stock Consolidation Approved

 
EXCH
KMPHARMACEUTICAL
★

Stock Split Decision (Par Value 500 KRW, 5:1 Merge, Schedule Change)

 
EXCH
KMPHARMACEUTICAL
★

Decision on Stock Split and Share Count Correction

 
EXCH
KMPHARMACEUTICAL
★

KM Pharma Calls EGM for Article Amendments and Executive Compensation Rules

 
EXCH
KMPHARMACEUTICAL
★

Record Date Set for 12th Extraordinary General Meeting

 
EXCH
KMPHARMACEUTICAL
★

Stock Consolidation Decision (5:1 Ratio) and Correction Notice